Westminster, CO, United States of America

Andrew D Padilla

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew D Padilla. Retrieved from https://idiyas.com/inventor/andrew-d-padilla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew D Padilla

Introduction

Andrew D Padilla is an accomplished inventor based in Westminster, CO (US). He has made significant strides in the field of pharmaceuticals and probiotics, showcasing his expertise through his innovative patents. His work focuses on enhancing the delivery of active ingredients in a stable liquid dosage form.

Latest Patents

One of Andrew D Padilla's notable patents is titled "Multiparticulate including pharmaceutical or probiotic active ingredients for delivery via a shelf stable liquid dosage form." This patent describes various embodiments of modified-release multiparticulates, which can include a core containing pharmaceutical and/or probiotic agents. The core may also incorporate additional excipients or binders to facilitate its creation. The invention features one or more functional coatings designed to provide a modified-release profile of the active ingredients when administered orally. Additionally, a coating of hypromellose acetate succinate (HPMCAS) is applied to ensure multiparticulate stability in aqueous acidic media. The patent also discusses suspensions that include these modified-release multiparticulates.

Career Highlights

Andrew D Padilla has demonstrated a commitment to innovation throughout his career. His work has led to the development of a unique approach to delivering pharmaceutical and probiotic agents, which can significantly impact patient care and treatment options. With 1 patent to his name, he continues to contribute to advancements in the field.

Collaborations

Throughout his career, Andrew has collaborated with talented individuals such as Dan A Finkbeiner and Roy J McDaniel. These partnerships have fostered a creative environment that encourages the development of groundbreaking ideas and solutions.

Conclusion

Andrew D Padilla's contributions to the field of pharmaceuticals and probiotics exemplify the spirit of innovation. His patented work on modified-release multiparticulates showcases his dedication to improving drug delivery systems. His ongoing efforts in this area are likely to yield further advancements in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…